Figure 2
GDF-15 levels decreased during treatment with deoxynucleosides. Development of GDF-15 (A,B) and FGF-21 (C,D) circulating concentrations (pg/mL) over time in group 1 (left) and group 2 (right) patients.
Figure 2 | Scientific Reports
GDF-15 levels decreased during treatment with deoxynucleosides. Development of GDF-15 (A,B) and FGF-21 (C,D) circulating concentrations (pg/mL) over time in group 1 (left) and group 2 (right) patients.
